Literature DB >> 33193917

COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Megan H St John1,2, Arden R Barry1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33193917      PMCID： PMC7605072          DOI： 10.1177/1715163520929373

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  32 in total

1.  Introduction.

Authors:  Robyn L Houlden
Journal:  Can J Diabetes       Date:  2018-04       Impact factor: 4.190

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.

Authors:  Luke J Burchill; Elena Velkoska; Rachael G Dean; Karen Griggs; Sheila K Patel; Louise M Burrell
Journal:  Clin Sci (Lond)       Date:  2012-12       Impact factor: 6.124

4.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

5.  Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.

Authors:  Yuichiro Ishiyama; Patricia E Gallagher; David B Averill; E Ann Tallant; K Bridget Brosnihan; Carlos M Ferrario
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

6.  Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.

Authors:  Giuseppe Mancia; Federico Rea; Monica Ludergnani; Giovanni Apolone; Giovanni Corrao
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

7.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.

Authors:  Mandeep R Mehra; Sapan S Desai; SreyRam Kuy; Timothy D Henry; Amit N Patel
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

8.  Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.

Authors:  David Gurwitz
Journal:  Drug Dev Res       Date:  2020-03-04       Impact factor: 5.004

9.  Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

Authors:  Muthiah Vaduganathan; Orly Vardeny; Thomas Michel; John J V McMurray; Marc A Pfeffer; Scott D Solomon
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

10.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586
View more
  1 in total

1.  Statin Use in Hospitalized Patients with COVID-19: A Comprehensive Analysis of the New York City Public Hospital System.

Authors:  Weijia Li; Saul Rios; Sanjana Nagraj; Adrija Hajra; Tinatin Saralidze; Dimitrios Varrias; Sheetal Vasundara Mathai; Marko Novakovic; Kenneth H Hupart; Jeremy A Miles; Adarsh Katamreddy; Leonidas Palaiodimos; Robert T Faillace
Journal:  Am J Med       Date:  2022-03-14       Impact factor: 5.928
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.